• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No place like home: initiation of non-invasive ventilation for stable severe COPD.

作者信息

Hill Nicholas S

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, Massachusetts, USA

出版信息

Thorax. 2020 Mar;75(3):196-197. doi: 10.1136/thoraxjnl-2019-213787. Epub 2020 Jan 29.

DOI:10.1136/thoraxjnl-2019-213787
PMID:31996402
Abstract
摘要

相似文献

1
No place like home: initiation of non-invasive ventilation for stable severe COPD.没有比家更好的地方：为稳定期重度慢性阻塞性肺疾病患者开始无创通气治疗
Thorax. 2020 Mar;75(3):196-197. doi: 10.1136/thoraxjnl-2019-213787. Epub 2020 Jan 29.
2
Noninvasive mechanical ventilation on the ward for severe COPD: still unresolved question of balance among safety and drawbacks?病房中对重度慢性阻塞性肺疾病患者进行无创机械通气：安全性与弊端之间的平衡问题仍未解决？
Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2209-2210. doi: 10.2147/COPD.S117861. eCollection 2016.
3
Early failure of noninvasive ventilation in COPD: All cornerstones under surveillance?慢性阻塞性肺疾病无创通气的早期失败：所有关键因素都在监测之中吗？
Intern Emerg Med. 2016 Jun;11(4):617-8. doi: 10.1007/s11739-015-1374-6. Epub 2015 Dec 28.
4
Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD).重度慢性阻塞性肺疾病（COPD）中需要机械通气的急性呼吸衰竭
Medicine (Baltimore). 2018 Apr;97(17):e0487. doi: 10.1097/MD.0000000000010487.
5
Home Noninvasive Ventilation to Reduce Readmissions for Chronic Obstructive Pulmonary Disease.家庭无创通气以减少慢性阻塞性肺疾病的再入院率
JAMA. 2017 Jun 6;317(21):2167-2169. doi: 10.1001/jama.2017.5226.
6
Home non-invasive mechanical ventilation use following acute hypercapnic respiratory failure in COPD. A solid protective factor.慢性阻塞性肺疾病急性高碳酸血症呼吸衰竭后家庭无创机械通气的使用。一个可靠的保护因素。
Respir Med. 2015 Sep;109(9):1233. doi: 10.1016/j.rmed.2015.07.001. Epub 2015 Jul 8.
7
Chronic respiratory failure in patients with chronic obstructive pulmonary disease under home noninvasive ventilation: Real-life study.慢性阻塞性肺疾病患者在家中接受无创通气治疗的慢性呼吸衰竭：真实世界研究。
Pulmonology. 2018 Sep-Oct;24(5):280-288. doi: 10.1016/j.pulmoe.2018.02.007. Epub 2018 Apr 5.
8
[A multi-centre randomized controlled trial of domiciliary non-invasive ventilation vs long-term oxygen therapy in survivors of acute hypercapnic respiratory failure due to COPD. Non-invasive ventilation in obstructive lung disease (NIVOLD) study].[一项关于慢性阻塞性肺疾病所致急性高碳酸血症呼吸衰竭幸存者家庭无创通气与长期氧疗的多中心随机对照试验。阻塞性肺疾病无创通气（NIVOLD）研究]
Rev Mal Respir. 2012 Nov;29(9):1141-8. doi: 10.1016/j.rmr.2012.09.006. Epub 2012 Oct 16.
9
[Effects of noninvasive proportional assist vs pressure support ventilation on respiratory work in chronic obstructive pulmonary disease patients with hypercapnia].[无创比例辅助通气与压力支持通气对慢性阻塞性肺疾病高碳酸血症患者呼吸功的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Jun 12;40(6):450-456. doi: 10.3760/cma.j.issn.1001-0939.2017.06.011.
10
[Application of sequential noninvasive following invasive mechanical ventilation in COPD patients with severe respiratory failure by investigating the appearance of pulmonary-infection-control-window].[通过观察肺部感染控制窗的出现探讨序贯无创-有创机械通气在慢性阻塞性肺疾病重症呼吸衰竭患者中的应用]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Feb;31(1):120-4.

引用本文的文献

1
Effect of Noninvasive Positive Pressure Ventilation on Prognosis and Blood Gas Level in COPD Patients Complicated with Respiratory Failure.无创正压通气对慢性阻塞性肺疾病合并呼吸衰竭患者预后及血气水平的影响
Evid Based Complement Alternat Med. 2022 Aug 5;2022:3089227. doi: 10.1155/2022/3089227. eCollection 2022.
2
Efficacy of nalmefene with noninvasive positive-pressure ventilation on elderly patients with chronic obstructive pulmonary disease combining with type II respiratory failure.纳美芬联合无创正压通气对老年慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者的疗效
Am J Transl Res. 2021 Nov 15;13(11):12949-12956. eCollection 2021.